Open navigation
Search
Search

Select your region

Elisa Fontaine
Senior Associate

Dr. Elisa Fontaine

Rechtsanwältin

Languages
  • German
  • English
Social media

Elisa Fontaine specialises in the life sciences and healthcare as well as related regulated sectors. She advises and represents clients mainly on pharmaceutical, medical device, product liability and medical law matters including public health law and the advertising and promotion of medicinal products. Her practice also covers the highly relevant topics of the digitalisation of healthcare, healthcare compliance and regulatory issues in healthcare. Advice on trademark and competition law completes her profile.

Elisa joined CMS in 2019.

Publications

  • Strafrechtliche Risiken Kl-basierter Diagnosesoftware für Ärzte, Medstra-Zeitschrift für Medizinstrafrecht, 4/2021, p. 203
  • Blogbeitrag "Corona-Tests. Diese Rechtsbasics sollten Sie kennen", CMS Deutschland bloggt, 14.12.2020 (mit Dr. Roland Wiring)
  • Blogbeitrag "Strohmanngeschäfte: Risiko Abrechnungsbetrug bei Medizinischen Versorgungszentren", CMS Deutschland bloggt, 03.11.2020 (mit Dr. Roland Wiring)
  • Blogbeitrag "Der Brexit und Medizinprodukte: Bald neue Regeln für den Marktzugang", CMS Deutschland bloggt, 04.09.2020 (mit Dr. Roland Wiring)

Education

  • 2020: PhD; thesis on a medical criminal law topic
  • 2017 - 2018: Research assistant to Prof. Dr Karsten Gaede, Bucerius Law School, Hamburg
  • 2016: Second state examination in law
  • 2014 - 2016: Trainee lawyer including placements in Berlin, London and Cape Town
  • 2013: First state examination in law
  • 2008 - 2013: Law studies at the University of Freiburg and the University of Muenster

Insights by Elisa

CMS advised all shareholders of AMW GmbH on sale to Ren Life Sciences and Juno Capital Partners

17 Mar 2026 2 min read

CMS advises Eqwal Group on the acquisition of Orthopädie-Technik Kurtze GmbH

13 Feb 2026 1 min read

CMS advises Gilde Healthcare on the acquisition of MEG Group from HQIB

17 Nov 2025 2 min read

CMS advises Eqwal Group on the acquisition of the Schindler orthopaedics group

13 Nov 2025 2 min read
Back to top Back to top